Search results
- 3.6700Add to watchlist+0.0100 (+0.27%)As of Thu. Sep 19, 2024 3:09 PM EDT · Nasdaq Real Time Price (USD) · Market open
- Open3.7450High3.8300Low3.6500
- Mkt Cap216.32MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close3.660052 Wk. Low1.350052 Wk. High6.8500
Related stocks
Get the latest information on PYXS stock, including price, performance, news, and analysis. Pyxis Oncology is a biotechnology company developing therapeutics to treat cancers with ADC and IO products.
Get the latest information on Pyxis Oncology Inc, a biotechnology company developing novel therapies for cancer, including its stock price, financial performance, market news, and more. See how PYXS compares to other biotech stocks and its peers in the NASDAQ.
Sep 9, 2024 · Pyxis Oncology is a biotech company developing next-generation therapeutics for cancer. See its stock price, performance, analyst ratings, news, and competitors on MarketWatch.
- 3.93%
- 1.48%
- 18.57%
- 90.00%
Discover real-time Pyxis Oncology, Inc. Common Stock (PYXS) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
6 days ago · Pyxis Oncology is a clinical stage company developing next generation therapeutics for difficult-to-treat cancers. See its stock price, news, financials, statistics, forecast, profile and chart on Stock Analysis.
- 214.26M
- 16.15M
- 59.20M
- 58.94M
May 1, 2024 · Get the latest stock price, volume, and trading data for PYXS on Nasdaq. See the 52 week range, high/low, and latest real-time trades for PYXS.
People also ask
Where can I buy Pyxis Oncology (PYXS) stock?
Where is Pyxis oncology headquartered?
Who is Pyxis oncology?
View the latest Pyxis Oncology Inc. (PYXS) stock price, news, historical charts, analyst ratings and financial information from WSJ.